Aminoterminal pro type B natriuretic peptide as a predictive and prognostic marker in patients with chronic heart failure

Journal of Heart and Lung Transplantation

Volumn 23, Issue 10, 2004, Pages 1189-1197

  Rothenburger, Markus ^a   Wichter, Thomas ^a   Schmid, Christof ^a   Stypmann, Jörg ^a   Tjan, Tonny D T ^a   Berendes, Elmar ^a   Etz, Christian ^a   Pioux, Aurélien ^a   Löher, Andreas ^a   Wenzelburger, Frauke ^a   Drees, Gabriele ^a   Hoffmeier, Andreas ^a   Breithardt, Günter ^a   Scheld, Hans Heinrich ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO TYPE B NATRIURETIC PEPTIDE; BIOCHEMICAL MARKER; BRAIN NATRIURETIC PEPTIDE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ASSISTED CIRCULATION; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART CATHETERIZATION; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOMES RESEARCH; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SPIROMETRY;

CARDIOMYOPATHY, DILATED; CORONARY ARTERIOSCLEROSIS; ECHOCARDIOGRAPHY; FEMALE; HEART CATHETERIZATION; HEART FAILURE, CONGESTIVE; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; NERVE TISSUE PROTEINS; PATIENT SELECTION; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; ROC CURVE; SPIROMETRY;

EID: 5144232593     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2004.07.006     Document Type: Article

References (33)

1. J.A. DeLemos, D.A. Morrow, J.H. Bentley The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes N Engl J Med 345 2001 1014 1021
2. A.S. Maisel, P. Krishnaswamy, R.M. Nowak Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure N Engl J Med 347 2002 161 167
3. P.A. McCullough, R.M. Nowak, J. McCord B-type natriuretic peptide and clinical judgement in emergency diagnosis of heart failure Circulation 106 2002 416 422
4. J. Mair, A. Hammerer-Lercher, B. Puschendorf The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure Clin Chem Lab Med 39 2001 571 588
5. D.L. Vesely Natriuretic peptides and acute renal failure Am J Physiol Renal Physiol 285 2003 F167 177
6. A.S. Maisel, J. McCord, R.M. Nowak Bedside B-type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction J Am Coll Cardiol 41 2003 2010 2017
7. L.K. Morrison, A. Harrison, P. Krishnaswamy Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnoea J Am Coll Cardiol 39 2002 202 209
8. K.D. Aaronson, J.S. Schartz, T.M. Chen Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation Circulation 95 1997 2660 2667
9. A.M. Richards, M.G. Nicholls, T.G. Yandle Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction Heart 81 1999 114 120
10. R.W. Schrier, W.T. Abraham Hormones and hemodynamics in heart failure N Engl J Med 341 1999 577 585
11. E.R. Levin, D.G. Gardner, W.K. Samson Natriuretic peptides N Engl J Med 339 1998 321 328
12. J.A. De Lemos, D.K. McGuire, M.H. Drazner B-type natriuretic peptide in cardiovascular disease Lancet 362 2003 316 322
13. H. Ruskoaho Cardiac hormones as diagnostic tools in heart failure Endocr Rev 24 2003 341 356
14. P. Jourdain, F. Funck, M. Bellorini Bedside B-type natriuretic peptide and functional capacity in chronic heart failure Eur J Heart Failure 5 2003 155 160
15. A. Koch, H. Singer Normal values of B type natriuretic peptide in infants, children, and adolescents Heart 89 2003 875 878
16. I. Raymond, B.A. Groenning, P.R. Hildebrandt The influence of age, sex, and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample ot the general population Heart 89 2003 745 751
17. J.P. Goetze, R. Videbaek, S. Boesgaard Pro-brain natriuretic peptide as marker of cardiovascular or pulmonary causes of dyspnea in patients with terminal parenchymal lung disease J Heart Lung Transplant 23 2004 80 87
18. A.M. Richards, M.G. Nicholls, E.A. Espiner B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction Circulation 107 2003 2786 2792
19. S.J. Wieczorek, A.H.B. Wu, R. Christenson A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure a multicenter evaluation Am Heart J 144 2002 834 839
20. T.R. Cimato, M. Jessup Recipient selection in cardiac transplantation contraindications and risk factors for mortality J Heart Lung Transplant 21 2002 1161 1173
21. J.A. Hanley, B.J. McNeil The meaning and use of the area under a receiver operating characteristic (ROC) curve Radiology 143 1982 29 36
22. R.S. Gardner, F. Özalp, A.J. Murday N-terminal pro-brain natriuretic peptide A new gold standard in predicting mortality in patients with advanced heart failure Eur Heart J 24 2003 1735 1743
23. M. Packer, A.J. Coats, M.B. Fowler Effect of carvedilol on survival in severe chronic heart failure N Engl J Med 344 2001 1651 1658
24. M. Packer, M.B. Fowler, E.B. Roecker Effect of carvedilol on the morbidity of patients with severe chronic heart failure results of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study Circulation 106 2002 2194 2199
25. C. Fisher, C. Berry, L. Blue N-terminal pro B type natriuretic peptide, but not the new putative cardiac hormone relaxin, predicts prognosis in patients with chronic heart failure Heart 89 2003 879 881
26. J.P. Goetze, C. Christoffersen, M. Perko Increased cardiac BNP expression associated with myocardial ischemia FASEB J 17 2003 U24 33
27. A.D. Struthers, A.D. Morris Screening for and treating left-ventricular abnormalities in diabetes mellitus a new way of reducing cardiac death Lancet 359 2002 1430 1432
28. J.G. Motwani, H. McAlpine, N. Kennedy Plasma brain natriuretic peptide as an indicator for angiotensin-converting enzyme inhibition after myocardial infarction Lancet 341 1993 1109 1113
29. F. Mallamaci, C. Zoccali, G. Tripepi Diagnostic potential of cardiac natriuretic peptides in dialysis patients Kidney Int 59 2001 1559 1566
30. A.M. Richards, R. Doughty, M.G. Nicholls Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction J Am Coll Cardiol 37 2001 1781 1787
31. T. Tsutamoto, A. Wada, K. Maeda Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction Circulation 96 1997 509 516
32. R. Berger, K. Strecker, M. Huelsmann Prognostic power of neurohormonal parameters in chronic heart failure depends on clinical stage and observation period J Heart Lung Transplant 22 2003 1037 1045
33. Selvais PL, Robert A, Ahn S, et al. Direct comparison between endothelin-1, N-terminal proatrial natriuretic factor, and brain natriuretic peptide as prognostic markers of survival in congestive heart failure.